Now its time to protect the results youve achieved
Medication program persistence and engagement: January 2026 analysis of 30,239 Noom GLP-1 Rx Program members who started a GLP-1Rx plan between December 2024 and February 2025, evaluating program persistence by engagement quartile
Women of reproductive age face greater risk because menstrual iron losses compound dietary deficiency
Every GLP-1 prescriber in the country now tells the patient the same thing: lift weights, eat protein, get to a gym
Staying at your current effective dose for a longer period can be a more strategic approach, especially if you are still experiencing appetite control without uncomfortable side effects
Experimental receptor activation influences mitochondrial function, substrate oxidation, and cellular energy efficiency, which are central to appetite-related metabolic adaptation studies